Yuichi Uwai

1.5k total citations
52 papers, 1.2k citations indexed

About

Yuichi Uwai is a scholar working on Pediatrics, Perinatology and Child Health, Oncology and Psychiatry and Mental health. According to data from OpenAlex, Yuichi Uwai has authored 52 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pediatrics, Perinatology and Child Health, 25 papers in Oncology and 21 papers in Psychiatry and Mental health. Recurrent topics in Yuichi Uwai's work include Drug Transport and Resistance Mechanisms (25 papers), Pharmacological Effects and Toxicity Studies (23 papers) and Bipolar Disorder and Treatment (19 papers). Yuichi Uwai is often cited by papers focused on Drug Transport and Resistance Mechanisms (25 papers), Pharmacological Effects and Toxicity Studies (23 papers) and Bipolar Disorder and Treatment (19 papers). Yuichi Uwai collaborates with scholars based in Japan and Italy. Yuichi Uwai's co-authors include Ken‐ichi Inui, Hideyuki Saito, Yukiya Hashimoto, Tomohiro Nabekura, Masahiro Okuda, Kikuo Iwamoto, Tatsuya Kawasaki, Toshiya Katsura, Hideyuki Motohashi and Hiroki Ida and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

Yuichi Uwai

50 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuichi Uwai Japan 18 634 416 263 227 146 52 1.2k
Suparat Khamdang Japan 10 749 1.2× 388 0.9× 183 0.7× 283 1.2× 123 0.8× 12 1.4k
Noriko Koyabu Japan 21 646 1.0× 379 0.9× 292 1.1× 301 1.3× 166 1.1× 31 1.3k
Masayuki Tsujimoto Japan 19 623 1.0× 316 0.8× 338 1.3× 289 1.3× 106 0.7× 76 1.3k
Michel Eichelbaum Germany 11 560 0.9× 388 0.9× 349 1.3× 150 0.7× 97 0.7× 14 931
Kelly Bleasby United States 16 674 1.1× 349 0.8× 236 0.9× 240 1.1× 57 0.4× 21 1.1k
Gustav Ahlin Sweden 7 813 1.3× 389 0.9× 245 0.9× 265 1.2× 45 0.3× 8 1.1k
Yong–Hae Han United States 19 584 0.9× 307 0.7× 295 1.1× 378 1.7× 100 0.7× 39 1.3k
KM Giacomini United States 17 715 1.1× 400 1.0× 323 1.2× 512 2.3× 56 0.4× 28 1.5k
Chie Emoto United States 24 453 0.7× 384 0.9× 667 2.5× 202 0.9× 56 0.4× 70 1.5k
Johanna Sistonen Finland 18 345 0.5× 300 0.7× 728 2.8× 242 1.1× 98 0.7× 34 1.3k

Countries citing papers authored by Yuichi Uwai

Since Specialization
Citations

This map shows the geographic impact of Yuichi Uwai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuichi Uwai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuichi Uwai more than expected).

Fields of papers citing papers by Yuichi Uwai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuichi Uwai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuichi Uwai. The network helps show where Yuichi Uwai may publish in the future.

Co-authorship network of co-authors of Yuichi Uwai

This figure shows the co-authorship network connecting the top 25 collaborators of Yuichi Uwai. A scholar is included among the top collaborators of Yuichi Uwai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuichi Uwai. Yuichi Uwai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakanishi, Kenji, Yuichi Uwai, & Tomohiro Nabekura. (2025). Vonoprazan-associated Microscopic Colitis and Continued Use After Onset: A Study Using a Japanese Pharmacovigilance Database. In Vivo. 39(4). 2363–2370.
3.
4.
Uwai, Yuichi & Tomohiro Nabekura. (2024). Relationship Between Clozapine and Non-Hematological Malignant Tumors: A Pharmacovigilance Analysis Using the FDA Adverse Event Reporting System Database. Drugs - Real World Outcomes. 11(2). 185–193. 2 indexed citations
7.
Nabekura, Tomohiro, et al.. (2020). Microtubule-targeting anticancer drug eribulin induces drug efflux transporter P-glycoprotein. Biochemistry and Biophysics Reports. 21. 100727–100727. 16 indexed citations
8.
Uwai, Yuichi, Tatsuya Kawasaki, & Tomohiro Nabekura. (2016). Foscarnet, an inhibitor of the sodium-phosphate cotransporter NaPi-IIa, inhibits phosphorylation of glycogen synthase kinase-3β by lithium in the rat kidney cortex. Drug Metabolism and Pharmacokinetics. 31(3). 256–259. 1 indexed citations
9.
Uwai, Yuichi, Tatsuya Kawasaki, & Tomohiro Nabekura. (2015). Minor contribution of biliary excretion in lithium elimination in rats. Drug Metabolism and Personalized Therapy. 30(1). 65–67. 3 indexed citations
10.
Uwai, Yuichi, et al.. (2014). Effect of selective cyclooxygenase-2 inhibitor lumiracoxib on phenolsulfonphthalein disposition in rats. Drug metabolism and drug interactions. 29(3). 203–206. 2 indexed citations
11.
Uwai, Yuichi, Tatsuya Kawasaki, & Tomohiro Nabekura. (2013). Caffeic acid inhibits organic anion transporters OAT1 and OAT3 in rat kidney. Drug metabolism and drug interactions. 28(4). 247–250. 8 indexed citations
12.
Uwai, Yuichi, et al.. (2013). Transport of Xanthurenic Acid by Rat/Human Organic Anion Transporters OAT1 and OAT3. Bioscience Biotechnology and Biochemistry. 77(7). 1517–1521. 10 indexed citations
13.
Uwai, Yuichi, et al.. (2011). Interaction and transport of kynurenic acid via human organic anion transporters hOAT1 and hOAT3. Pharmacological Research. 65(2). 254–260. 60 indexed citations
14.
Uwai, Yuichi & Kikuo Iwamoto. (2010). Transport of Aminopterin by Human Organic Anion Transporters hOAT1 and hOAT3: Comparison with Methotrexate. Drug Metabolism and Pharmacokinetics. 25(2). 163–169. 13 indexed citations
15.
Uwai, Yuichi, et al.. (2010). Inhibitory Effect of Selective Cyclooxygenase-2 Inhibitor Lumiracoxib on Human Organic Anion Transporters hOAT1 and hOAT3. Drug Metabolism and Pharmacokinetics. 25(5). 450–455. 6 indexed citations
16.
Uwai, Yuichi, et al.. (2007). Interaction and transport characteristics of mycophenolic acid and its glucuronide via human organic anion transporters hOAT1 and hOAT3. Biochemical Pharmacology. 74(1). 161–168. 36 indexed citations
17.
Uwai, Yuichi, et al.. (2004). Methotrexate-Loxoprofen Interaction: Involvement of Human Organic Anion Transporters hOAT1 and hOAT3. Drug Metabolism and Pharmacokinetics. 19(5). 369–374. 74 indexed citations
18.
Masuda, Satohiro, et al.. (2002). Organic Anion Transporter oatp2-Mediated Interaction between Digoxin and Amiodarone in the Rat Liver. Pharmaceutical Research. 19(6). 738–743. 42 indexed citations
19.
Uwai, Yuichi, Hideyuki Saito, Yukiya Hashimoto, & Ken‐ichi Inui. (2000). Interaction and Transport of Thiazide Diuretics, Loop Diuretics, and Acetazolamide via Rat Renal Organic Anion Transporter rOAT1. Journal of Pharmacology and Experimental Therapeutics. 295(1). 261–265. 82 indexed citations
20.
Hashimoto, Yukiya, et al.. (1997). Genetic polymorphism of the CYP2C subfamily and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy*. Clinical Pharmacology & Therapeutics. 62(3). 287–292. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026